InvestorsHub Logo
Followers 6
Posts 519
Boards Moderated 0
Alias Born 06/26/2013

Re: The Claw post# 8271

Sunday, 07/21/2013 5:27:17 PM

Sunday, July 21, 2013 5:27:17 PM

Post# of 24848
CB, I don't know what to say about all of that DD. It's amazing that those funds have the early outlook on SCRC. Now I see where the funding is going to be coming from for this SCRC. They have a heavy hitter.

"In addition, Implex will assist ScripsAmerica in any negotiations and structuring of the sale and/or purchase of businesses, mergers, strategic alliances or distribution agreements as well as advise on the sale of any securities in the public market.

"2013 is going to be a very positive and pivotal year for ScripsAmerica as we plan to launch our RapiMed line of children's pain reliever, finalize the acquisition of our pharmaceutical distributor, explore opportunities to continue our organic growth and increase shareholder value. For these reasons, we have engaged Implex Corporation to provide ScripsAmerica with a full range of investment banking services such as financial analysis and advice as well as introductions to the appropriate players in the investment community that can help ensure our success during this anticipated period of significant growth," stated Bob Schneiderman, CEO of ScripsAmerica."